Search Within

Lymphoma

Formats
  1. Meeting Abstract (1382)
  2. Journal Article (1056)
  3. Book Section (64)
  4. Review (64)
  5. Editorial (38)
  6. Research Letter (38)
  7. Guidelines (18)
  8. Conference Paper (15)
  9. Correspondence (11)
  10. Miscellaneous (5)
  11. Book Whole (4)
Groups
  1. Center for Hematologic Malignancies (2695)
  2. Department of Medicine (2695)
  3. Hematologic Malignancies, Division of (2695)
  4. Population Sciences Research Program (742)
  5. Survivorship Research (655)
  6. Executive Committee, Center for Hematologic Malignancies (391)

More Groups

People
  1. Andrew Zelenetz (781)
  2. Steven Horwitz (664)
  3. Maria Palomba (444)
  4. Ariela Noy (369)
  5. David Straus (360)
  6. Alison Moskowitz (355)

More People

Years
  1. 2025 (42)
  2. 2024 (141)
  3. 2023 (180)
  4. 2022 (170)
  5. 2021 (171)
  6. 2020 (170)

More Years

Publications
  1. Blood (876)
  2. Journal of Clinical Oncology (277)
  3. Hematological Oncology (110)
  4. British Journal of Haematology (81)
  5. Leukemia and Lymphoma (81)
  6. Haematologica (71)

More Publications

Publishers
  1. American Society of Hematology (941)
  2. American Society of Clinical Oncology (293)
  3. Elsevier Inc. (187)
  4. Wiley Blackwell (174)
  5. John Wiley & Sons (96)
  6. Nature Publishing Group (93)

More Publishers

Results (2695)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • FDG-PET adapted sequential therapy with brentuximab vedotin and augmented ICE followed by autologous stem cell transplant for relapsed and refractory Hodgkin lymphoma
    Meeting Abstract

    Moskowitz, A.; Schoder, H.; Gerecitano, J. F.; Hamlin, P.; Horwitz, S. M.; Matasar, M. J.; Keskinyan, V. S.; McCall, S.; Noy, A.; Palomba, M. L.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • A proposed prognostic model for overall survival in the oldest old (>80 years old) follicular lymphoma patients
    Meeting Abstract

    Nabhan, C.; Byrtek, M.; Dawson, K. L.; Zhou, X.; Link, B. K.; Friedberg, J. W.; Zelenetz, A. D.; Cerhan, J. R.; Flowers, C. R.
    Blood (2013)

    Fulltext@MSK | Save
  • Identification of actionable genomic alterations in hematologic malignancies by a clinical next generation sequencing-based assay
    Meeting Abstract

    Lipson, D.; Nahas, M. K.; Otto, G. A.; Yelensky, R.; Abdel-Wahab, O.; Wang, K.; He, J.; Intlekofer, A. M.; Rampal, R. K.; Brennan, T. A.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Excellent outcomes for limited-stage diffuse large B-cell lymphoma in the rituximab era: A retrospective analysis from Memorial Sloan-Kettering Cancer Center
    Meeting Abstract

    Kumar, A.; Maragulia, J. C.; Lunning, M. A.; Moskowitz, C. H.; Zelenetz, A. D.
    Blood (2013)

    Fulltext@MSK | Save
  • Profiling genomic alterations of diffuse large B-cell lymphoma (DLBCL) at diagnosis, relapse, and transformation, using a novel clinical diagnostic targeted sequencing platform
    Meeting Abstract

    Intlekofer, A. M.; Sheshan, V. E.; Levine, R. L.; Zelenetz, A. D.; Teruya-Feldstein, J.; Dogan, A.; Palomba, M. L.; Moskowitz, C. H.; van den Brink, M. R. M.; Knapp, K. M.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Autologous stem cell transplant is a feasible treatment for older relapsed and refractory Hodgkin lymphoma patients
    Meeting Abstract

    Glick, H.; Lee, C.; Sauter, C. S.; Moskowitz, C. H.; Matasar, M. J.
    Blood (2013)

    Fulltext@MSK | Save
  • Long term results of a phase 2 study of vincristine sulfate liposome injection (Marqibo) substituted for non-liposomal vincristine in CHOP with or without rituximab for patients with untreated aggressive non-Hodgkin's lymphomas
    Meeting Abstract

    Hagemeister, F. B.; Rodriguez, M. A.; Deitcher, S. R.; Younes, A.; Fayad, L.; Goy, A.; Dang, N. H.; Forman, A.; McLaughlin, P.; Pro, B.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Impact of induction regimen and consolidative stem cell transplantation in patients with double hit lymphoma (DHL): A large multicenter retrospective analysis
    Meeting Abstract

    Gandhi, M.; Petrich, A. M.; Cassaday, R. D.; Press, O. W.; Shah, K.; Whyman, J.; Lansigan, F.; Zelenetz, A. D.; Shah, N.; Fenske, T. S.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Extensive high-depth sequencing of longitudinal CLL samples identifies frequent mutations in MAP kinase signaling and novel mutations activating notch and beta-catenin
    Meeting Abstract

    Gardner, J. R.; Nahas, M. K.; He, J.; Patel, M.; Knapp, K. M.; Palomba, M. L.; Yelensky, R.; Donahue, A. L.; Otto, G. A.; Arcila, M.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Preliminary safety and efficacy of IPI-145, a potent inhibitor of phosphoinositide-3-kinase-δ,γ, in patients with chronic lymphocytic leukemia
    Meeting Abstract

    Flinn, I.; Patel, M.; Kahl, B. S.; Horwitz, S. M.; Foss, F. M.; Oki, Y.; Porcu, P.; Sweeney, J.; Allen, K.; Faia, K.; more...
    Blood (2013)

    Fulltext@MSK | Save